Abstract
This study describes the model design of the NCUEE-NLP system for the SemEval-2023 NLI4CT task that focuses on multi-evidence natural language inference for clinical trial data. We use the LinkBERT transformer in the biomedical domain (denoted as BioLinkBERT) as our main system architecture. First, a set of sentences in clinical trial reports is extracted as evidence for premise-statement inference. This identified evidence is then used to determine the inference relation (i.e., entailment or contradiction). Finally, a soft voting ensemble mechanism is applied to enhance the system performance. For Subtask 1 on textual entailment, our best submission had an F1-score of 0.7091, ranking sixth among all 30 participating teams. For Subtask 2 on evidence retrieval, our best result obtained an F1-score of 0.7940, ranking ninth of 19 submissions.- Anthology ID:
- 2023.semeval-1.107
- Volume:
- Proceedings of the 17th International Workshop on Semantic Evaluation (SemEval-2023)
- Month:
- July
- Year:
- 2023
- Address:
- Toronto, Canada
- Editors:
- Atul Kr. Ojha, A. Seza Doğruöz, Giovanni Da San Martino, Harish Tayyar Madabushi, Ritesh Kumar, Elisa Sartori
- Venue:
- SemEval
- SIG:
- SIGLEX
- Publisher:
- Association for Computational Linguistics
- Note:
- Pages:
- 776–781
- Language:
- URL:
- https://aclanthology.org/2023.semeval-1.107
- DOI:
- 10.18653/v1/2023.semeval-1.107
- Cite (ACL):
- Chao-Yi Chen, Kao-Yuan Tien, Yuan-Hao Cheng, and Lung-Hao Lee. 2023. NCUEE-NLP at SemEval-2023 Task 7: Ensemble Biomedical LinkBERT Transformers in Multi-evidence Natural Language Inference for Clinical Trial Data. In Proceedings of the 17th International Workshop on Semantic Evaluation (SemEval-2023), pages 776–781, Toronto, Canada. Association for Computational Linguistics.
- Cite (Informal):
- NCUEE-NLP at SemEval-2023 Task 7: Ensemble Biomedical LinkBERT Transformers in Multi-evidence Natural Language Inference for Clinical Trial Data (Chen et al., SemEval 2023)
- PDF:
- https://preview.aclanthology.org/dois-2013-emnlp/2023.semeval-1.107.pdf